Edition:
United States

Eagle Pharmaceuticals Inc (EGRX.OQ)

EGRX.OQ on NASDAQ Stock Exchange Global Market

57.40USD
15 Dec 2017
Change (% chg)

-- (--)
Prev Close
$57.40
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
128,575
52-wk High
$97.14
52-wk Low
$45.05

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Michael Graves

54 2016 Independent Chairman of the Board

Scott Tarriff

57 2017 Chief Executive Officer, Independent Director

Pete Meyers

47 2017 Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer

David Riggs

65 2013 Chief Financial Officer

Steven Krill

57 2015 Executive Vice President, Chief Scientific Officer